Word

PHARMEXA

Status

Dead

Status Code

710

Status Date

Friday, May 30, 2014

Serial Number

78090584

Registration Number

3319312

Registration Date

Tuesday, October 23, 2007

Mark Type

1000

Filing Date

Monday, October 29, 2001

Published for Opposition

Tuesday, March 4, 2003

Cancellation Date

Friday, May 30, 2014

Trademark Owner History

Pharmexa A-S - Original Registrant

Classifications

1 Chemical products for use in the development of pharmaceuticals, vaccines, namely, therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use

5 Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA

42 Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotecnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely, in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research

Trademark Events

May 30, 2014

Cancelled Sec. 8 (6-Yr)

Oct 23, 2007

Registered-Principal Register

Sep 19, 2007

Law Office Registration Review Completed

Sep 19, 2007

Assigned To Lie

Aug 14, 2007

Allowed Principal Register - Sou Accepted

Jul 30, 2007

Assigned To Examiner

Jul 3, 2007

Statement Of Use Processing Complete

Mar 26, 2007

Use Amendment Filed

Mar 26, 2007

Teas Statement Of Use Received

Sep 25, 2006

Extension 3 Granted

Sep 25, 2006

Extension 3 Filed

Sep 25, 2006

Teas Extension Received

May 2, 2006

Extension 2 Granted

May 2, 2006

Extension 2 Filed

May 2, 2006

Teas Extension Received

Nov 26, 2005

Extension 1 Granted

Nov 1, 2005

Extension 1 Filed

Nov 1, 2005

Paper Received

May 3, 2005

Noa Mailed - Sou Required From Applicant

Jan 23, 2005

Extension Of Time To Oppose Process - Terminated

Sep 10, 2004

Case File In Ticrs

Apr 15, 2003

Extension Of Time To Oppose Received

Mar 4, 2003

Published For Opposition

Feb 12, 2003

Notice Of Publication

Dec 30, 2002

Approved For Pub - Principal Register

Nov 18, 2002

Correspondence Received In Law Office

Dec 6, 2002

Reinstated

Nov 5, 2002

Abandonment - Failure To Respond Or Late Response

Jun 25, 2002

Correspondence Received In Law Office

Jan 28, 2002

Non-Final Action Mailed

Jan 25, 2002

Assigned To Examiner